novo nordisk glp-1 patent litigation The Heavy Price of Drugs: How Financialization Drives Pharmaceutical Abuse and Health Inequities for GLP-1 Therapies – I-MAK Ozempic, Wegovy and Rybelsus: The
Description
This Drug Will Disrupt Everything
Adv Ther 2022;39(4):17721783
Acknowledgements We thank Milena Braga-Basaria, MD (Voxmed Medical Communications) for critically reviewing and suggesting improvements to the manuscript
Mctabi and Dr
